FAQFAQ and Resources (EUA) for the Treatment of COVID-19BamlanivimabHealthcare Providers:Safety InformationLimitations of Authorized UseImportant Safety InformationHypersensitivity Including Anaphylaxis and Infusion-Related ReactionsLimitations of Benefit and Potential Risk in Patients with Severe COVID-19Adverse EventsUse in Specific Populations
